KR970703333A - 5-HT_1A 길항제로서의 피페라진 유도체(Piperazine derivatives as 5-HT_1A antagonists) - Google Patents
5-HT_1A 길항제로서의 피페라진 유도체(Piperazine derivatives as 5-HT_1A antagonists) Download PDFInfo
- Publication number
- KR970703333A KR970703333A KR1019960706880A KR19960706880A KR970703333A KR 970703333 A KR970703333 A KR 970703333A KR 1019960706880 A KR1019960706880 A KR 1019960706880A KR 19960706880 A KR19960706880 A KR 19960706880A KR 970703333 A KR970703333 A KR 970703333A
- Authority
- KR
- South Korea
- Prior art keywords
- hydrogen
- methyl
- compound according
- formula
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
본 발명은 임의로 약제학적으로 허용되는 산 부가염의 형태인 하기 화학식 (A)의 화합물에 관한 것이다.
상기 식에서, Ra및 Rb는 각각 수소 또는 메틸이고, Rc는 수소, 할로 또는 C1-4알킬이다.
상기 화합물은 CNS 질환의 치료에 유용하다.
Description
5-HT1A길항제로서의 피페라진 유도체(Piperazine derivatives as 5-HT1Aantagonists)
[도면의 간단한 설명]
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (14)
- 화학식 (A)의 화합물 또는 약제학적으로 허용되는 이의 산 부가염.상기 식에서, Ra및 Rb는 각각 수소 또는 메틸이고, Rc는 수소, 할로 또는 C1-4알킬이다.
- 제1항에 있어서, Rc가 수소인 화합물.
- (R)-N-(1-메틸-2-(4-인돌릴-l-피페라지닐에틸)-N-(2-피리딜)사이클로헥산카복스아미드 또는 약제학적으로 허용되는 이의 산 부가염.
- (R)-N-(2-메틸-(4-인돌릴-1-피페라지닐)에틸)-N-(2-(피리딜)사이클로헥산카복스아미드 또는 약제학적으로 허용되는 이의 산 부가염.
- N-[2-(4-(4-인돌릴)-1-피페라지닐)에틸]-N-(2-피리딜)사이클로헥산카복스아미드 또는 약제학적으로 허용되는 이의 산 부가염.
- 약제학적으로 허용되는 희석제 또는 담체와 배합된 제1항 내지 제5항 중 어느 한 항에 따른 화합물을 포함하는 약제학적 조성물.
- CNS 질환의 치료에 있어서, 제1항 내지 제5항 중 어느 한 항에 따른 화합물의 용도.
- CNS 질환의 치료용 약제를 제조하기 위한, 제1항 내지 제5항 중 어느 한 항에 따른 화합물의 용도.
- CNS 질환의 치료를 필요로 하는 포유동물에게 제1항 내지 제5항 중 어느 한 항에 따른 화합물의 유효량을 투여함을 포함하는, 상기 CNS 질환의 치료 방법.
- 화학식 (B)의 아민.상기 식에서, Ra및 Rb는 각각 수소 또는 메틸이다.
- 화학식(B)의 아민을 사이클로헥산카복실산 또는 이의 아실화 유도체로 아실화시킴을 포함하는, 제2항 내지 제5항 중 어느 한 항에 따른 화합물의 제조방법.상기 식에서, Ra및 Rb는 각각 수소 또는 메틸이다.
- 화학식의 아미드를 화학식(여기서, Ra및 Rb는 각각 수소 또는 메틸이고, X1은 할로겐이거나 알킬- 또는 아릴-설포닐옥시 그룹과 같은 이탈 그룹이다)의 알킬화제로 아릴화시킴을 포함하는, 제2항 내지 제5항 중 어느 한항에 따른 화합물의; 제조방법.
- 화학식 (C)의 화합물을 화학식(여기서, Ra및 Rb는 각각 수소 또는 메틸이고, X1은 할로겐이거나 알킬- 또는 아릴-설포닐옥시 그룹과 같은 이탈 그룹이다)의 화합물로 알킬화시킴을 포함하는, 제2항 내지 제5항 중 어느 한 항에 따른 화합물의 제조방법.
- 화학식의 Nind-보호된 유도체와 2-플루오로피리딘 N-옥사이드를 반응시킨 다음 연속해서 보호 그룹과 N-옥사이드 그룹을 제거함을 포함하는, 제2항 내지 제5항 중 어느 한 항에 따른 화합물의 제조방법.※ 참고사항:최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9411099.6 | 1994-06-03 | ||
GB9411099A GB9411099D0 (en) | 1994-06-03 | 1994-06-03 | Piperazine derivatives |
JP95-80396 | 1995-04-05 | ||
JP95-85637 | 1995-04-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR970703333A true KR970703333A (ko) | 1997-07-03 |
KR100359393B1 KR100359393B1 (ko) | 2003-01-24 |
Family
ID=10756114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960706880A KR100359393B1 (ko) | 1994-06-03 | 1995-06-01 | 5-ht1a 길항제로서의 피페라진유도체 및 이의 제조방법 |
Country Status (25)
Country | Link |
---|---|
US (1) | US5723464A (ko) |
EP (1) | EP0763031B1 (ko) |
JP (1) | JPH10500989A (ko) |
KR (1) | KR100359393B1 (ko) |
CN (2) | CN1048985C (ko) |
AT (1) | ATE192744T1 (ko) |
AU (1) | AU680147B2 (ko) |
BR (1) | BR9507910A (ko) |
CA (1) | CA2191871C (ko) |
CZ (1) | CZ287381B6 (ko) |
DE (1) | DE69516867T2 (ko) |
DK (1) | DK0763031T3 (ko) |
ES (1) | ES2145275T3 (ko) |
FI (1) | FI114985B (ko) |
GB (1) | GB9411099D0 (ko) |
GR (1) | GR3033449T3 (ko) |
HU (1) | HUT76466A (ko) |
IL (1) | IL113967A (ko) |
MX (1) | MX9605915A (ko) |
NZ (2) | NZ331452A (ko) |
PT (1) | PT763031E (ko) |
RU (1) | RU2165933C2 (ko) |
SK (1) | SK281418B6 (ko) |
WO (1) | WO1995033743A1 (ko) |
ZA (1) | ZA954525B (ko) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU645681B2 (en) * | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
DK0763024T3 (da) * | 1994-06-03 | 2002-12-02 | Wyeth John & Brother Ltd | Fremgangmåde og mellemprodukter til fremstilling af piperazinderivater |
CA2194984C (en) * | 1994-07-26 | 2002-07-02 | John Eugene Macor | 4-indole derivatives as serotonin agonists and antagonists |
US5486518A (en) * | 1995-04-10 | 1996-01-23 | American Home Products Corporation | 4-indolylpiperazinyl derivatives |
US5519025A (en) * | 1995-04-10 | 1996-05-21 | American Home Products Corporation | 4-indolylpiperazinyl derivatives |
IT1282705B1 (it) * | 1996-02-28 | 1998-03-31 | Recordati Chem Pharm | Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria |
US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
DE19615232A1 (de) * | 1996-04-18 | 1997-10-23 | Merck Patent Gmbh | Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten |
DE19725664A1 (de) * | 1997-06-18 | 1998-12-24 | Merck Patent Gmbh | 3-Benzylpiperidine |
US6399614B1 (en) | 1997-08-01 | 2002-06-04 | Recordati S.A. Chemical And Pharmaceutical Company | 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring |
US6271234B1 (en) | 1997-08-01 | 2001-08-07 | Recordati S.A., Chemical And Pharmaceutical Company | 1,4-disubstituted piperazines |
JP2001512110A (ja) * | 1997-08-01 | 2001-08-21 | レコルダチ エッセ.ア.,ケミカル アンド ファーマシューティカル カンパニー | 1,4−ジ置換ピペラジン |
IT1293807B1 (it) * | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico |
IT1293804B1 (it) | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | Diarilalchilpiperazine attive sulle basse vie urinarie |
US6376494B1 (en) | 1998-06-15 | 2002-04-23 | American Home Products Corporation | Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
CN1312802A (zh) * | 1998-06-15 | 2001-09-12 | 美国家用产品公司 | 作为5-羟色胺能药物的环烷基取代的芳基哌嗪、哌啶和四氢吡啶 |
US20060223824A1 (en) | 2000-11-28 | 2006-10-05 | Wyeth | Serotonergic agents |
US20060287335A1 (en) | 2000-11-28 | 2006-12-21 | Wyeth | Serotonergic agents for treating sexual dysfunction |
JPWO2002070482A1 (ja) * | 2001-02-27 | 2004-07-02 | 鐘淵化学工業株式会社 | 光学活性n−アリール−1−アミノ−2−プロパノール誘導体の製造法 |
CN101492383A (zh) | 2002-03-12 | 2009-07-29 | 惠氏公司 | 制备手性1,4-二取代哌嗪的方法 |
US7091349B2 (en) | 2002-03-12 | 2006-08-15 | Wyeth | Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution |
US7361773B2 (en) | 2002-03-12 | 2008-04-22 | Wyeth | Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
CN1982307A (zh) * | 2002-03-12 | 2007-06-20 | 惠氏公司 | 合成手性n-芳基哌嗪的方法 |
SI1483243T1 (sl) | 2002-03-12 | 2007-08-31 | Wyeth Corp | Priprava n1- (2'-piridil)-1,2-propandiamin sulfamske kisline in uporaba spojine za sintezo bioloĺ ko aktivnih piperazinov |
US7179813B2 (en) * | 2003-06-11 | 2007-02-20 | Wyeth | Bicyclic indolyl derivatives and methods for their use as serotonergic agents |
CN100436448C (zh) * | 2003-06-11 | 2008-11-26 | 惠氏公司 | 二环吲哚基衍生物以及其作为5-羟色胺能活性剂的应用 |
TW200800959A (en) | 2005-06-10 | 2008-01-01 | Wyeth Corp | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor |
US20080032965A1 (en) * | 2006-06-09 | 2008-02-07 | Hirst Warren D | Method for enhancing cognitive function |
CA2951259A1 (en) | 2014-06-06 | 2015-12-10 | Flexus Biosciences, Inc. | Immunoregulatory agents |
AR102537A1 (es) | 2014-11-05 | 2017-03-08 | Flexus Biosciences Inc | Agentes inmunomoduladores |
MX2017005462A (es) | 2014-11-05 | 2017-07-28 | Flexus Biosciences Inc | Agentes inmunorreguladores. |
UY36390A (es) | 2014-11-05 | 2016-06-01 | Flexus Biosciences Inc | Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8909209D0 (en) * | 1989-04-22 | 1989-06-07 | Wyeth John & Brother Ltd | Piperazine derivatives |
KR0173310B1 (ko) * | 1989-04-22 | 1999-02-01 | 폴 에이 리쳐 | 피페라진 유도체 |
GB9021535D0 (en) * | 1990-10-03 | 1990-11-14 | Wyeth John & Brother Ltd | Piperazine derivatives |
AU645681B2 (en) * | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
SE9201138D0 (sv) * | 1992-04-09 | 1992-04-09 | Astra Ab | Novel phthalimidoalkylpiperazines |
GB9300195D0 (en) * | 1993-01-06 | 1993-03-03 | Wyeth John & Brother Ltd | Piperazine derivatives |
-
1994
- 1994-06-03 GB GB9411099A patent/GB9411099D0/en active Pending
-
1995
- 1995-06-01 ES ES95921017T patent/ES2145275T3/es not_active Expired - Lifetime
- 1995-06-01 SK SK1541-96A patent/SK281418B6/sk unknown
- 1995-06-01 RU RU97100151/04A patent/RU2165933C2/ru not_active IP Right Cessation
- 1995-06-01 PT PT95921017T patent/PT763031E/pt unknown
- 1995-06-01 EP EP95921017A patent/EP0763031B1/en not_active Expired - Lifetime
- 1995-06-01 DE DE69516867T patent/DE69516867T2/de not_active Expired - Fee Related
- 1995-06-01 KR KR1019960706880A patent/KR100359393B1/ko not_active IP Right Cessation
- 1995-06-01 WO PCT/GB1995/001263 patent/WO1995033743A1/en active IP Right Grant
- 1995-06-01 MX MX9605915A patent/MX9605915A/es not_active IP Right Cessation
- 1995-06-01 NZ NZ331452A patent/NZ331452A/xx unknown
- 1995-06-01 CN CN95193383A patent/CN1048985C/zh not_active Expired - Fee Related
- 1995-06-01 DK DK95921017T patent/DK0763031T3/da active
- 1995-06-01 IL IL11396795A patent/IL113967A/xx not_active IP Right Cessation
- 1995-06-01 CZ CZ19963507A patent/CZ287381B6/cs not_active IP Right Cessation
- 1995-06-01 HU HU9603315A patent/HUT76466A/hu unknown
- 1995-06-01 AT AT95921017T patent/ATE192744T1/de not_active IP Right Cessation
- 1995-06-01 NZ NZ287498A patent/NZ287498A/xx unknown
- 1995-06-01 AU AU26230/95A patent/AU680147B2/en not_active Ceased
- 1995-06-01 ZA ZA954525A patent/ZA954525B/xx unknown
- 1995-06-01 CA CA002191871A patent/CA2191871C/en not_active Expired - Fee Related
- 1995-06-01 JP JP8500531A patent/JPH10500989A/ja not_active Withdrawn
- 1995-06-01 BR BR9507910A patent/BR9507910A/pt not_active Application Discontinuation
- 1995-06-02 US US08/459,205 patent/US5723464A/en not_active Expired - Lifetime
-
1996
- 1996-12-02 FI FI964815A patent/FI114985B/fi active IP Right Grant
-
1998
- 1998-11-10 CN CN98122461A patent/CN1093122C/zh not_active Expired - Fee Related
-
2000
- 2000-05-19 GR GR20000401137T patent/GR3033449T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR970703333A (ko) | 5-HT_1A 길항제로서의 피페라진 유도체(Piperazine derivatives as 5-HT_1A antagonists) | |
JP3274865B2 (ja) | 5−htレセプター拮抗物質としてのピペラジン誘導体 | |
RU97100151A (ru) | Производные пиперазина в качестве антагонистов 5нт1а | |
DE60218445T2 (de) | Inhibierung der raf-kinase durch chinolin-, isochinolin- oder pyridin-harnstoffe | |
US20020165394A1 (en) | Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas | |
EP0891354B1 (en) | N-aminoalkyldibenzofurancarboxamides as dopamine receptor subtype specific ligands | |
CA2516370A1 (en) | A process of preparing imatinib and imatinib prepared thereby | |
JP5112297B2 (ja) | イオンチャネルのモジュレーターとして有用なキノリン誘導体 | |
CA2436980A1 (en) | Amido ether substituted imidazoquinolines | |
JO2294B1 (en) | 4 - Phenylpyridine derivatives | |
PL338129A1 (en) | Crystalline form of a derivative of n-phenyl-2-dipyrimidin amine, methods of obtaining same and apllication thereof | |
SK280133B6 (sk) | Piperazínové deriváty, spôsob ich výroby, farmaceu | |
IS4593A (is) | Bensimídazól efnasambönd, lyfjablöndur sem innihalda efnasamböndin og notkun þeirra | |
CA2463968A1 (en) | Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors | |
DE68902209D1 (de) | Imidazolin-derivate und verfahren zu deren herstellung. | |
ATE318266T1 (de) | 3-substituierte chinolin-4- carbonsäureamidderivate als nk-3- und nk-2- rezeptorantagonisten | |
WO1997034889A1 (en) | N-aminoalkyldibenzothiophenecarboxamides; dopamine receptor subtype specific ligands | |
ATE361918T1 (de) | 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2- yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden | |
PT74507B (de) | Substituierte 3-amino-sydnonimine verfahren zu ihrer herstel- lung und ihre verwendung | |
KR950014103A (ko) | 1-[2H-1-벤조피란-2-온-8-일]-피페라진 유도체(1-[2H-1-benzopyran-2-one-8-yl]-piperazine derivatives) | |
RU2001126547A (ru) | Производные дифенила | |
JP2021506810A (ja) | フッ素化4−(置換アミノ)フェニルカルバメート誘導体 | |
YU64901A (sh) | Derivati bifenila | |
KR910004598A (ko) | 2,3-디하이드로-1-(피리디닐아미노)-인돌, 이의 제조방법 및 약제로서 이의 용도 | |
JPH08507779A (ja) | 5‐ht1aリガンドとしてのアミド誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |